Form 10-Q BIOGEN INC. For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Oil slips as Saudi Arabia offers more crude via Oman
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Exclusive-SK Hynix in talks with Intel about deal to make memory chips in US for the first time, sources say
- Trade the FOMC: How stocks tend to perform on Fed hike days
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Bernstein on Crypto: 'Clarity fails - what next?'
Biogen (BIIB) PT Lowered to $386 at Needham & Company
October 21, 2021 6:26 AM EDTNeedham & Company analyst Ami Fadia lowered the price target on Biogen (NASDAQ: BIIB) to $386.00 (from $398.00) while maintaining a Buy rating.
The analyst commented, "While near term earnings remain strong, driven by the MS franchise, Aduhelm's uptake is essentially pushed out to after CMS's final... More
Biogen (BIIB) PT Lowered to $390 at Oppenheimer
October 20, 2021 6:05 PM EDTOppenheimer analyst Jay Olson lowered the price target on Biogen (NASDAQ: BIIB) to $390.00 (from $450.00) while maintaining an Outperform rating.
The analyst commented, "Bolstered by a 3Q top- and bottom-line beat, BIIB outlined a number of steps to support the Aduhelm launch but deferred... More
